Compound Edaravone Injection for Acute Ischemic Stroke

Completed

Phase 2 Results N/A

Summary of Purpose

1. To investigate the efficacy and safety of multi-doses Compound Edaravone Injection versus Edaravone Injection for acute ischemic stroke patients; 2. To provide evidence for the design of Compound Edaravone Injection Phase III trial.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 July 2015.

1 Aug 2013 22 Aug 2013 1 Dec 2014 1 Feb 2015 1 Jul 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available